Administration of monophosphoryl lipid A shortly after traumatic brain injury blocks the following spatial and avoidance memory loss and neuroinflammation
Scientific Reports · 2024
DOI: 10.1038/s41598-024-80331-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Maryam Hooshmand und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Lipid A, Neuroinflammatory Diseases, Memory Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pasteur Institute of Iran.
Abstract (Originalsprache)
Traumatic brain injury (TBI) frequently leads to cognitive impairments. The toll-like receptor 4 (TLR4) ligand, Monophosphoryl lipid A (MPL), has shown promise in modulating neuroinflammatory responses after TBI. We investigated the effects of MPL on spatial memory, passive avoidance memory, neuronal survival, and inflammatory/anti-inflammatory cytokines in rat brain following mild-to-moderate TBI. Rats underwent a learning period in the Morris water maze and shuttle box, followed by TBI induction by controlled cortical impact. MPL was administered into the cerebral ventricle 20 min after TBI. Spatial memory was assessed 7 and 28 days later. Passive avoidance memory was assessed 2 and 6 days after TBI. MPL significantly improved the spatial memory deficit at 7 days but not 28 days after TBI. It also improved impairment of the avoidance memory at both 2 and 6 days after TBI. MPL prohibited the TBI-induced TNF-α increase and IL-10 decrease in the injured region at 7 days post-TBI period. MPL prevented the neuronal loss induced by TBI in the hippocampus. A single administration of MPL shortly after TBI alleviates short-term memory deficits, through anti-inflammatory and anti-cell loss activities. Repeated MPL administration may also inhibit the long-term memory deficits after TBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
- Department of Physiology and Pharmacology, Pasteur Institute of Iran, Tehran, Iran.
- Department of Biochemistry, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
- Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran. asoodeh@um.ac.ir.
- Department of Physiology and Pharmacology, Pasteur Institute of Iran, Tehran, Iran. h_gholamipour@pasteur.ac.ir.
- Department of Physiology, Faculty of Veterinary Medicine, Tehran University, Tehran, Iran.
ORCID-Profile: Ahmad Asoodeh, Hamid Gholami Pourbadie, Mohamad Sayyah
Förderung
- Pasteur Institute of Iran
Zitieren
APA
Hooshmand, M., Sadeghi, M. R., Asoodeh, A., Pourbadie, H. G., Mehni, M. K., & Sayyah, M. (2024). Administration of monophosphoryl lipid A shortly after traumatic brain injury blocks the following spatial and avoidance memory loss and neuroinflammation. Scientific Reports. https://doi.org/10.1038/s41598-024-80331-3
Vancouver
Hooshmand M, Sadeghi MR, Asoodeh A, Pourbadie HG, Mehni MK, Sayyah M. Administration of monophosphoryl lipid A shortly after traumatic brain injury blocks the following spatial and avoidance memory loss and neuroinflammation. Scientific Reports. 2024. doi:10.1038/s41598-024-80331-3
BibTeX
@article{Hooshmand2024,
author = {Hooshmand, Maryam and Sadeghi, Mohammad Reza and Asoodeh, Ahmad and Pourbadie, Hamid Gholami and Mehni, Mahbobeh Kamrani and Sayyah, Mohamad},
title = {Administration of monophosphoryl lipid A shortly after traumatic brain injury blocks the following spatial and avoidance memory loss and neuroinflammation},
journal = {Scientific Reports},
year = {2024},
doi = {10.1038/s41598-024-80331-3}
}
EUVIMED